Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  American Journal of Pathology

• Publication date

  1989-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 2683796PMCID PMC1880109
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies on the role of lipoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta.

  2009cited by this paper
• Low density lipoprotein undergoes oxidative modification in vivo.

  1989cited by this paper
• Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits.

  1988cited by this paper
• Monoclonal DLR1a/104G antibody recognizing peroxidized lipoproteins in atherosclerotic lesions.

  1988cited by this paper
• Superoxide initiates oxidation of low density lipoprotein by human monocytes.

  1987cited by this paper
• Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.

  1987cited by this paper
• Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.

  1987cited by this paper
• Cyclophosphamide treatment used to manipulate the immune response for the production of monoclonal antibodies.

  1987cited by this paper
• Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100.

  1987cited by this paper
• Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits.

  1987cited by this paper
• Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells.

  1986cited by this paper
• Oxidized low density lipoprotein induces ceroid accumulation by murine peritoneal macrophages in vitro.

  1986cited by this paper
• Conservation of the Low Density Lipoprotein Receptor‐Binding Domain of Apoprotein B

  1986cited by this paper
• Macrophage Oxidation of Low Density Lipoprotein Generates a Modified Form Recognized by the Scavenger Receptor

  1986cited by this paper
• Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions.

  1986cited by this paper
• Probucol inhibits oxidative modification of low density lipoprotein.

  1986cited by this paper
• Mechanisms Involved in the Uptake and Degradation of Low Density Lipoprotein by the Artery Wall in Vivo a

  1985cited by this paper
• The distribution of ceroid in human atherosclerosis

  1985cited by this paper
• Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein.

  1985cited by this paper
• Monocytes and Neutrophils Oxidize Low Density Lipoprotein Making It Cytotoxic

  1985cited by this paper
• Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture.

  1984cited by this paper
• Endothelial and Smooth Muscle Cells Alter Low Density Lipoprotein In Vitro by Free Radical Oxidation

  1984cited by this paper
• Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.

  1984cited by this paper
• Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.

  1983cited by this paper
• Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid.

  1983cited by this paper
• Monoclonal antibodies to intermediate filament proteins of human cells: unique and cross- reacting antibodies

  1982cited by this paper
• Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.

  1981cited by this paper
• Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.

  1980cited by this paper
• Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor.

  1980cited by this paper
• Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition.

  1979cited by this paper
• Microsomal lipid peroxidation.

  1978cited by this paper

• Targeted anti-inflammatory therapy is a new insight for reducing cardiovascular events: A review from physiology to the clinic.

  2020cites this paper
• Associations between circulating IgG antibodies to Apolipoprotein B100-derived peptide antigens and acute coronary syndrome in a Chinese Han population

  2018cites this paper
• Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)

  2018cites this paper
• Lysosomal oxidation of Low Density Lipoproteins

  2017cites this paper
• Plasma levels of lipid and cholesterol oxidation products and in diabetes mellitus and cigarette smoking : of vitamin treatment

  2017cites this paper
• Human pericoronary adipose tissue as storage and possible supply site for oxidized low-density lipoprotein and high-density lipoprotein in coronary artery.

  2017cites this paper
• Lipoprotein-Associated Oxidative Stress

  2016cites this paper
• Impact of Anti-Oxidized Low- Density Lipoprotein Antibodies in Heart Failure and Coronary Artery Disease. Role of Antioxidants

  2016influential citation
• Pericoronary Adipose Tissue as Storage and Supply Site for Oxidized Low-Density Lipoprotein in Human Coronary Plaques

  2016cites this paper
• Roles of antibody against oxygenized low density lipoprotein in atherosclerosis: recent advances.

  2015cites this paper
• Restoring Immune Tolerance in Atherosclerosis: Role of Regulatory Immune Response in Atheroprotection.

  2015cites this paper
• Roles of theWHHL Rabbit in Translational Research on Hypercholesterolemia and Cardiovascular Diseases

  2014cites this paper
• Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis

  2014cites this paper
• Radioiodinated peptide probe for selective detection of oxidized low density lipoprotein in atherosclerotic plaques.

  2013cites this paper
• Diagnostic and Prognostic Value of Low Density Lipoprotein-Containing Circulating Immune Complexes in Atherosclerosis

  2013cites this paper
• Screening for and Management of Elevated Lp(a)

  2013cites this paper
• Immunological detection of large oxidized lipoproteins in hypertriglyceridemic serum

  2013cites this paper
• Immune Response to Lipoproteins in Atherosclerosis

  2012cites this paper
• Role of NKT cell activation in malondialdehyde-modified low density lipoprotein immunization for atherosclerosis prevention

  2012cites this paper
• Novel monoclonal antibody recognizing triglyceride-rich oxidized LDLs associated with severe liver disease and small oxidized LDLs in normal subjects

  2012cites this paper
• Model IgG Monoclonal Autoantibody–Anti-Idiotype Pair for Dissecting the Humoral Immune Response to Oxidized Low Density Lipoprotein

  2012cites this paper
• Lipoproteins as biosensors of endothelial oxidative status

  2012cites this paper
• regions adjacent to prosthetic grafts in cholesterol-fed rabbits Probucol reduces the cellularity of aortic intimal thickening at anastomotic

  2011cites this paper
• The Discovery of LOX-1, its Ligands and Clinical Significance

  2011cites this paper
• a 361,662

  2011cites this paper
• Roles of the WHHL Rabbit in Translational Research on Hypercholesterolemia and Cardiovascular Diseases

  2011cites this paper
• and cell-mediated oxidation PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper-

  2011cites this paper
• Vascular pathology in the aged human brain

  2010cites this paper
• Immune Modulation as a Therapeutic Strategy for Atherosclerosis

  2010cites this paper
• The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: a tribute to the late Dr. Yoshio Watanabe.

  2009cites this paper
• Natural antibodies in murine atherosclerosis.

  2008cites this paper
• Atherosclerosis, antiphospholipid syndrome, and antiphospholipid antibodies.

  2007cites this paper
• Oxidation of Low-Density Lipoprotein Cholesterol Following Administration of Poloxamer 407 to Mice Results From an Indirect Effect

  2007cites this paper
• The Role of Chlamydia pneumoniae-induced Platelet Activation in Cardiovascular Disease : In vitro and In vivo studies

  2007cites this paper
• Lipoproteins and Oxidation

  2006cites this paper
• Scoparia dulcis reduces the severity of Trypanosoma bruceiinduced hyperlipidaemia in the rabbit

  2006cites this paper
• The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma.

  2006cites this paper
• Chapter 2 LIPOPROTEINS AND OXIDATION

  2006cites this paper
• Adoptive Transfer of CD4+ T Cells Reactive to Modified Low-Density Lipoprotein Aggravates Atherosclerosis

  2006cites this paper
• [Binding Characterizations of Asp-hemolysin to Oxidized Low-Density Lipoprotein].

  2005cites this paper
• Ex vivo measures of LDL oxidative susceptibility predict carotid artery disease.

  2005cites this paper
• Apolipoprotein E modulation of vascular smooth muscle cell response to injury.

  2005cites this paper
• Serum Lipids and Lipoproteins Profile in Hypertensive Patients Reporting for Treatment at Central Hospital, Benin City, Nigeria

  2005cites this paper
• Atherosclerosis: immunopathogenesis and immunotherapy.

  2004cites this paper
• Reduced progression of atherosclerosis in apolipoprotein E‐deficient mice treated with lacidipine is associated with a decreased susceptibility of low‐density lipoprotein to oxidation

  2004cites this paper
• Lipoprotein-matrix interactions in macrovascular disease in diabetes.

  2004cites this paper
• Role of oxidative modifications in atherosclerosis.

  2004cites this paper
• Are Anti–Oxidized Low-Density Lipoprotein Antibodies Pathogenic or Protective?

  2004cites this paper
• Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits

  2004cites this paper
• Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction

  2003cites this paper
• Antioxidant nutrients protect against cyclosporine A nephrotoxicity.

  2003cites this paper
• Effects of LDL, cholesterol, and their oxidized forms on the precipitation kinetics of calcium phosphates.

  2003cites this paper
• ANTIOXIDANT NUTRIENTS PROTECT AGAINST CYCLOSPORINE A NEPHROTOXICITY

  2003cites this paper
• CD4+ T cells in atherosclerosis.

  2003cites this paper
• The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol‐lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis

  2002cites this paper
• Modulation of versican expression by smooth muscle cells and myofibroblasts in cardiovascular disease

  2002cites this paper
• Inhibition of human LDL oxidation by the neuroprotective drug l-deprenyl

  2002cites this paper
• Localization of oxidation-specific epitopes in tissue.

  2002cites this paper
• [29] Localization of oxidation-specific epitopes in tissue

  2002cites this paper
• Lysosomal regulation of gene expression.

  2002cites this paper
• Antibody to oxidized low-density lipoprotein and cardiovascular mortality in end-stage renal disease.

  2002cites this paper
• Antioxidative activity of green tea polyphenol in cholesterol-fed rats.

  2002cites this paper
• Assay methods of modified lipoproteins in plasma.

  2002cites this paper
• Antioxidants, Nutrition and Health

  2001cites this paper
• LDL Immunization Induces T-Cell–Dependent Antibody Formation and Protection Against Atherosclerosis

  2001cites this paper
• Anion-exchange high-performance liquid chromatography assays of plasma lipoproteins and modified low-density lipoproteins using a ProtEx-DEAE column.

  2001cites this paper
• Autoantibodies Against Oxidized Palmitoyl Arachidonoyl Phosphocholine in Atherosclerosis

  2001cites this paper
• Hypochlorite-modified (lipo)proteins are present in rabbit lesions in response to dietary cholesterol.

  2001cites this paper
• Circulating Autoantibodies to Oxidized LDL Correlate With Arterial Accumulation and Depletion of Oxidized LDL in LDL Receptor–Deficient Mice

  2001cites this paper
• Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications.

  2001cites this paper
• Development of atherosclerotic plaque with endothelial disruption in Watanabe heritable hyperlipidemic rabbit aortas.

  2001cites this paper
• Oxidized LDL bind to nonproteoglycan components of smooth muscle extracellular matrices.

  2001cites this paper
• Oxidized low-density lipoprotein and autoimmune antibodies in patients with antiphospholipid syndrome with a history of thrombosis.

  2001cites this paper
• Ascorbic acid protects against peroxidative modification of low-density lipoprotein, maintaining its recognition by LDL receptors.

  2001cites this paper
• Oxidized low density lipoprotein: the occurrence and metabolism in circulation and in foam cells.

  2000cites this paper
• The preparation of copper-oxidized LDL for the measurement of oxidized LDL antibodies by EIA.

  2000cites this paper
• Evidence of modified LDL in the plasma of hypercholesterolemic WHHL rabbits injected with aqueous extracts of cigarette smoke.

  2000cites this paper
• Comparative analysis of plasma and erythrocyte 7-ketocholesterol as a marker for oxidative stress in patients with diabetes mellitus.

  2000cites this paper
• Effect of vitamin E supplementation on antibody levels against malondialdehyde modified LDL in hyperlipidemic hamsters.

  2000cites this paper
• Highly Sensitive to Their Regression Provides an Accurate Measure of Atherosclerotic Lesions Rich in Oxidized LDL and Is In Vivo Uptake of Radiolabeled MDA 2 , an Oxidation-Specific Monoclonal Antibody

  2000cites this paper
• Oxidized Low Density Lipoprotein (ox-LDL) Binding to ox-LDL Receptor-1 in Endothelial Cells Induces the Activation of NF-κB through an Increased Production of Intracellular Reactive Oxygen Species*

  2000cites this paper
• The Oxidative Modification Hypothesis of Atherogenesis

  2000cites this paper
• Nilvadipine protects low-density lipoprotein cholesterol from in vivo oxidation in hypertensive patients with risk factors for atherosclerosis

  2000cites this paper
• In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression.

  2000cites this paper
• Stimulating effect of biologically modified low density lipoproteins on ADP-induced aggregation of washed platelets persists in absence of specific binding.

  2000cites this paper
• APA hamster model for diabetic atherosclerosis. 2. Analysis of lipids and lipoproteins.

  2000cites this paper
• A Novel Antibody to Oxidized Phosphatidylethanolamine That Is Specific for Amino Groups Modified by Lipid Peroxides

  2000cites this paper
• Inhibitory effects of fluvastatin and its metabolites on hydrogen peroxide-induced oxidative destruction of hemin and low-density lipoprotein.

  2000cites this paper
• Autoantibody against oxidized low-density lipoproteins may be enhanced by cigarette smoking.

  2000cites this paper
• Potential role of oxidized lipids and lipoproteins in antioxidant defense

  2000cites this paper
• Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo

  1999cites this paper
• Suppressive effects of vitamin E-coated dialysis membrane on hemodialysis-induced neutrophil activation.

  1999cites this paper
• Red wine inhibits the cell-mediated oxidation of LDL and HDL.

  1999cites this paper
• Modélisation de la cinétique d’oxydation des LDL par un logiciel (logiciel NELOP) et validation dans une population à risques vasculaires

  1999cites this paper
• Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.

  1999cites this paper
• Protection of low density lipoprotein oxidation by the antioxidant agent IRFI005, a new synthetic hydrophilic vitamin E analogue.

  1999cites this paper
• In vitro inhibitory effects of the optical isomers and metabolites of fluvastatin on copper ion-induced LDL oxidation.

  1999cites this paper
• Demonstration of the presence of lipid peroxide-modified proteins in human atherosclerotic lesions using a novel lipid peroxide-modified anti-peptide antibody.

  1999cites this paper
• CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta.

  1999cites this paper
• Quantitative immunohistochemical detection of oxidized low density lipoprotein in the rabbit arterial wall.

  1999cites this paper